Pacer Advisors’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,126
Closed -$49K 1515
2021
Q1
$49K Buy
+1,126
New +$49K ﹤0.01% 1441